According to the latest report by IMARC Group titled “US Healthcare Advertising Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on the US healthcare advertising market trends.
The US healthcare advertising market reached a value of US$ 21.3 Billion in 2021. Looking forward, the market is anticipated to reach a value of US$ 28.1 Billion by 2027, at a projected CAGR of 4.81% over the forecast period of 2022-2027. Healthcare advertising is a marketing strategy that involves brand promotion and dissemination of information regarding diseases and pharmaceutical products to outreach a broader consumer base. It involves newspapers, magazines, medical journals, television commercials, internet advertising, search engine optimization (SEO), public relations (PR), and social media ads as standard formats. These promotional strategies mitigate misinformation, sensitize consumers regarding diverse medicines and their usage, create brand identity, and enhance reach in the competitive landscape. Consequently, healthcare advertising is used by pharmaceutical manufacturers and brands to promote and sell medical insurance, over-the-counter (OTC) medicines, and hygiene, fitness, and diet products and services.
Request a Free PDF Sample of the Report: https://www.imarcgroup.com/us-healthcare-advertising-market/requestsample
US Healthcare Advertising Market Trends:
The rapid digital transformation and the increasing need for effective healthcare product marketing strategies, such as direct-to-consumer pharmaceutical advertising (DTCPA), to increase the consumer base are primarily driving the market growth. Moreover, the investments being made by healthcare organizations in SEO-optimized online display ads, brand websites, and social media to raise awareness regarding diseases, health services, lab tests, and preventive measures are favoring the market growth. In addition, the increasing availability of the escalating number of alternative therapies and treatments in the medical field is encouraging manufacturers to leverage advertising to gain a competitive edge in the market. Besides this, extensive celebrity endorsements and the uptake of social media campaigns to inform the public regarding internet pharmacies, new drug launches, healthcare reforms, and the availability of generic and me-too drugs are providing lucrative opportunities for market growth.
Competitive Landscape With Key Players:
The competitive landscape of the US healthcare advertising market has been studied in the report with the detailed profiles of the key players operating in the market.
Some of these key players include:
- Johnson Johnson Services, Inc.
- Pfizer Inc.
- Merck Co., Inc.
- GlaxoSmithKline plc.
- Eli Lilly and Company
- Novartis International AG
- Sanofi S.A
- AstraZeneca PLC
- Hoffmann-La Roche Ltd. (Roche)
- Bayer AG
- Bristol- Myers Squibb (BMS).
Key Market Segmentation:
The report has segmented the US healthcare advertising market on the basis of product type.
Breakup by Product Type:
- Pharmaceuticals (Small Molecule Drugs)
- Biopharmaceuticals
- Vaccines
- Over-the-Counter (OTC) Drugs
Ask Analyst for Customization and Explore Full Report With TOC List of Figures: https://www.imarcgroup.com/us-healthcare-advertising-market
Key Highlights of the Report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Market Trends
- Market Drivers and Success Factors
- Impact of COVID-19
- Value Chain Analysis
- Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe Africa: +44-753-713-2163 | Asia: +91-120-433-0800
